Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: SPSEIFERT who wrote (23958)	8/5/1998 3:32:00 AM
From: bob zagorin	Read Replies (2) \| Respond to of 32384

we have already discussed isip and vicl, two very good biotechs, leaders in their fields who have been hammered worse than lgnd lately even with nothing but good news. here's two more, both of which i own - rzym, which keeps announcing collaborations and good news, is now down to 3.25 having been as high as 19-20 two years ago. i bought in at 5.5 thinking i found the bottom...wrong. axph (axys) is a great co., again a leader in its field with major collaborations all over the place, it's down to 6 from about 10 earlier this year, again on nothing but good news. so let's all be real here. lgnd's drop has nothing to do with henry; and tony and his boys have no insight either as he was touting vicl on this thread at 19. i switched some of my money into biotechs earlier this year because i was worried that asia might knock the techs down and the biotechs would not get caught in that problem. seemed logical but so far not so good. they still seem like a great long term investment.